These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37433350)

  • 41. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
    Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
    Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin:
    Mashaqbeh H; Obaidat R; Al-Shar'i NA; El-Elimat T; Alnabulsi S
    Res Pharm Sci; 2022 Aug; 17(4):334-349. PubMed ID: 36034082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents.
    Carvalho SG; Cipriano DF; de Freitas JCC; Junior MÂS; Ocaris ERY; Teles CBG; de Jesus Gouveia A; Rodrigues RP; Zanini MS; Villanova JCO
    Drug Deliv Transl Res; 2020 Dec; 10(6):1788-1809. PubMed ID: 32803562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Porous and highly responsive cross-linked β-cyclodextrin based nanomatrices for improvement in drug dissolution and absorption.
    Badshah SF; Akhtar N; Minhas MU; Khan KU; Khan S; Abdullah O; Naeem A
    Life Sci; 2021 Feb; 267():118931. PubMed ID: 33359243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization, thermodynamic parameters and in vivo antimalarial activity of inclusion complexes of artemether.
    Chadha R; Gupta S; Shukla G; Jain DS; Singh S
    Drug Discov Ther; 2010 Jun; 4(3):190-201. PubMed ID: 22491183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Amin S
    Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19.
    Abou Taleb S; Moatasim Y; GabAllah M; Asfour MH
    J Drug Deliv Sci Technol; 2022 Nov; 77():103921. PubMed ID: 36338534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment.
    Abbas ZS; Sulaiman GM; Jabir MS; Mohammed SAA; Khan RA; Mohammed HA; Al-Subaiyel A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation.
    Wang Q; Zhang K; Weng W; Chen L; Wei C; Bao R; Adu-Frimpong M; Cao X; Yu Q; Shi F; Toreniyazov E; Ji H; Xu X; Yu J
    J Pharm Sci; 2022 Jul; 111(7):2083-2092. PubMed ID: 35367247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
    Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies.
    Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Trandafirescu C; Ledeți I
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Lipophilic Salt Form to Enhance the Lipid Solubility and Certain Biopharmaceutical Properties of Lapatinib.
    Singh N; Chakravarti R; Das A; Gupta S; Ghosh D; Datta P
    Mol Pharm; 2024 Jun; ():. PubMed ID: 38935681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.
    Ahad A; Bin Jardan YA; Hassan MZ; Raish M; Ahmad A; Al-Mohizea AM; Al-Jenoobi FI
    Drug Deliv; 2022 Dec; 29(1):1512-1522. PubMed ID: 35549506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
    Mukne AP; Nagarsenker MS
    AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Host-Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives.
    Andor M; Temereancă C; Sbârcea L; Ledeți A; Man DE; Mornoș C; Ridichie A; Cîrcioban D; Vlase G; Barvinschi P; Caunii A; Văruţ RM; Trandafirescu CM; Buda V; Ledeți I; Rădulescu M
    Molecules; 2024 May; 29(10):. PubMed ID: 38792072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.